PMA device
Navistar Diagnostic/Ablation Deflectable Tip Catheter
Biosense Webster, Inc. · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Nov 24, 2009, newest Mar 7, 2013Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
19
Naming "Navistar"
MAUDE reports
0
Brand "Navistar", since 2015
PubMed studies
32
Mentioning "Navistar"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Navistar Diagnostic/Ablation Deflectable Tip Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Navistar", any status and sponsor, newest update first.
- The Best Workflow for Paroxysmal Supraventricular Tachycardia Ablation With Zero-fluoroscopyEnrolling by invitation
National Taiwan University HospitalAcademic, hospital or other
NCT07361055 · 70 participants (planned) · Start Mar 26, 2025 · Primary completion Dec 31, 2027
Device: Protocol A; Protocol B · For: Cardio Vascular Disease; Cryoablation
Sites: Taipei, Taiwan
Biosense Webster, Inc.Public (JNJ)
NCT00721149 · 10 participants · Start Sep 2008 · Primary completion Dec 2009
Device: Radiofrequency Ablation · For: Heart Diseases; Arrhythmia; Atrial Fibrillation
- nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial FibrillationPivotal-lookingTerminated
Biosense Webster, Inc.Public (JNJ)
NCT01824394 · 481 participants · Start Apr 1, 2013 · Primary completion Nov 26, 2017
Device: nMARQ Navigation Catheters; NaviStar ThermoCool Catheters · For: Atrial Fibrillation
16 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Navistar", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LPB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Navistar"[tiab]. The summary above synthesizes these.
- 3D transvenous radiofrequency ablation of manifest epicardial posterior-septal accessory pathways in children: Can technology innovations improve the outcome?
Drago F, Tamborrino PP, Pazzano V, et al. · Cardiol Young · 2022
- Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study.
Acosta J, Penela D, Andreu D, et al. · Europace · 2018Comparative Study, Randomized Controlled Trial
- NaviStar ThermoCool catheter for ventricular tachycardia.
Abdelwahab A, Sapp JL · Expert Rev Med Devices · 2007Review
- Tricking CARTO: Cryoablation of Supraventricular Tachycardia in Children with Minimal Radiation Exposure Using the CARTO3 System.
Ceresnak SR, Nappo L, Janson CM, et al. · Pacing Clin Electrophysiol · 2016
- Impact of Electrode Type on Mapping of Scar-Related VT.
Berte B, Relan J, Sacher F, et al. · J Cardiovasc Electrophysiol · 2015
- Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
Marchlinski FE, Haffajee CI, Beshai JF, et al. · J Am Coll Cardiol · 2016Clinical Trial, Multicenter Study
- Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study.
Hindricks G, Willems S, Kautzner J, et al. · J Cardiovasc Electrophysiol · 2009Comparative Study, Multicenter Study
- Circuit Impedance Could Be a Crucial Factor Influencing Radiofrequency Ablation Efficacy and Safety: A Myocardial Phantom Study of the Problem and its Correction.
Bhaskaran A, Barry MA, Pouliopoulos J, et al. · J Cardiovasc Electrophysiol · 2016
- Monophasic action potential mapping in swine and humans using modified-tip ablation catheter and electroanatomic mapping system.
Liu S, Yuan S, Hertervig E, et al. · Scand Cardiovasc J · 2002Research Support, Non-U.S. Gov't
- Importance of anticoagulation and postablation silent cerebral lesions: Subanalyses of REVOLUTION and reMARQable studies.
Grimaldi M, Swarup V, DeVille B, et al. · Pacing Clin Electrophysiol · 2017Comparative Study, Multicenter Study
- Luminal esophageal temperature rise and esophageal lesion formation following remote-controlled magnetic pulmonary vein isolation.
Konstantinidou M, Wissner E, Chun JK, et al. · Heart Rhythm · 2011
- Magnetic guidance versus manual control: comparison of radiofrequency lesion dimensions and evaluation of the effect of heart wall motion in a myocardial phantom.
Bhaskaran A, Barry MA, Al Raisi SI, et al. · J Interv Card Electrophysiol · 2015Comparative Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LPB.
- Therapy Ablation Catheter (4mm and 8mm)Irvine Biomedical, Inc. · PMA 2022
- Navistar ThermocoolBiosense Webster, Inc. · PMA 2014
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Blazer II Cardiac Ablation System and CableBoston Scientific Corp · PMA 2025
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.